Brīvība, M.; Atava, I.; Pečulis, R.; Elbere, I.; Ansone, L.; Rozenberga, M.; Silamiķelis, I.; Kloviņš, J.
Evaluating the Efficacy of Type 2 Diabetes Polygenic Risk Scores in an Independent European Population. Int. J. Mol. Sci. 2024, 25, 1151.
https://doi.org/10.3390/ijms25021151
AMA Style
Brīvība M, Atava I, Pečulis R, Elbere I, Ansone L, Rozenberga M, Silamiķelis I, Kloviņš J.
Evaluating the Efficacy of Type 2 Diabetes Polygenic Risk Scores in an Independent European Population. International Journal of Molecular Sciences. 2024; 25(2):1151.
https://doi.org/10.3390/ijms25021151
Chicago/Turabian Style
Brīvība, Monta, Ivanna Atava, Raitis Pečulis, Ilze Elbere, Laura Ansone, Maija Rozenberga, Ivars Silamiķelis, and Jānis Kloviņš.
2024. "Evaluating the Efficacy of Type 2 Diabetes Polygenic Risk Scores in an Independent European Population" International Journal of Molecular Sciences 25, no. 2: 1151.
https://doi.org/10.3390/ijms25021151
APA Style
Brīvība, M., Atava, I., Pečulis, R., Elbere, I., Ansone, L., Rozenberga, M., Silamiķelis, I., & Kloviņš, J.
(2024). Evaluating the Efficacy of Type 2 Diabetes Polygenic Risk Scores in an Independent European Population. International Journal of Molecular Sciences, 25(2), 1151.
https://doi.org/10.3390/ijms25021151